Kearns & Associates’s Morgan Stanley MS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$212K Sell
1,125
-375
-25% -$79.7K 0.1% 37
2026
Q2
$314K Hold
1,500
– – 0.15% 34
2026
Q1
$247K Hold
1,500
– – 0.13% 36
2025
Q4
$266K Hold
1,500
– – 0.14% 39
2025
Q3
$238K Hold
1,500
– – 0.13% 40
2025
Q2
$211K Buy
+1,500
New +$184K 0.12% 42

Other funds holding MS

Kearns & Associates's MS Position: Q3 2026 in Review

Kearns & Associates reduced its Morgan Stanley (MS) stake by 25% in Q3 2026, selling an estimated $79.7K and leaving 1,125 shares worth $212K. The position accounts for 0.1% of the portfolio, ranked #37.

Kearns & Associates first reported a position in MS in Q2 2025 and has held it in 6 quarters since. The position peaked at $314K in Q2 2026. 1,693 funds tracked by Wall St. Rank hold MS as of Q3 2026.

  • Kearns & Associates held 1,125 shares of Morgan Stanley worth $212K as of Q3 2026.
  • Kearns & Associates sold 375 Morgan Stanley shares in Q3 2026, an estimated $79.7K.
  • Morgan Stanley made up 0.1% of Kearns & Associates's portfolio in Q3 2026, its #37 holding.
  • Kearns & Associates first reported a position in Morgan Stanley in Q2 2025 and has held it in 6 quarters since.
  • Kearns & Associates's Morgan Stanley position peaked at $314K in Q2 2026.
  • 1,693 funds tracked by Wall St. Rank held Morgan Stanley as of Q3 2026.

Based on Kearns & Associates's 13F filing for Q3 2026, filed 9 Oct 2026.